Please wait a minute...
欢迎访问发育医学电子杂志,今天是
发育医学电子杂志  2025, Vol. 13 Issue (4): 261-267    DOI: 10.3969/j.issn.2095-5340.2025.04.003
  围产医学   论著 |产科 |
孕妇外周血 miR-195、miR-191-5p 与子痫前期病情程度的关系及联合预测妊娠结局的价值
黄利  钱学飞   徐金凤  李思琪
1. 成都市青白江区人民医院 妇产科,四川 成都 610000;2. 四川大学华西第二医院 特需门诊 出生缺陷与相关妇儿疾病教育部重点实验室,四川 成都 610041)
Relationship between miR-195, miR-191-5p in peripheral blood of pregnant women and the severity of preeclampsia, and the value of combined prediction of pregnancy outcomes
Huang Li, Qian Xuefei , Xu Jinfeng, et al
(1. Department of Obstetrics and Gynecology, Chengdu Qingbaijiang District People's Hospital, Sichuan, Chengdu 610000, China; 2. Key Laboratory of Birth Defects andRelated Gynecological and Pediatric Diseases of Ministry of Education, Special Needs Clinic, West China Second University Hospital, Sichuan University, Sichuan, Chengdu 610041, China)

下载:  PDF (1015KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 【摘要】 目的  研究孕妇外周血微小 RNA-195(miR-195)、微小 RNA-191-5p(miR-191-5p)与子痫前期病情程度的关系,以及两者联合检测对妊娠结局的预测价值。 方法 采用前瞻性研究方法,选取2022 年 1 月至 2023 年 6 月成都市青白江区人民医院收治的 124 例子痫前期孕妇作为观察组,同期产检的 124 例正常孕妇作为对照组。采用实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction,RT-qPCR)法检测外周血 miR-195、miR-191-5p mRNA 的表达量,分析不同病情程度、不同妊娠结局子痫前期孕妇外周血 miR-195、miR-191-5p mRNA 表达量的差异,分析外周血 miR-195、miR-191-5p mRNA 表达量与子痫前期孕妇病情程度、妊娠结局的相关性及预测子痫前期孕妇妊娠结局的效能。统计学方法采用 t 检验、χ2 检验、Pearson 相关性分析、受试者工作特征(receiver operating characteristic,ROC)曲线分析及多因素 Logistic 回归分析。 结果  观察组孕妇外周血 miR-195 mRNA 表达量低于对照组(0.49±0.09 与 1.00±0.12,t=37.860,P<0.05),miR-191-5p mRNA 表达量高于对照组(1.65±0.23 与 1.00±0.10,t=28.860,P<0.05)。重度子痫前期孕妇外周血 miR-195 mRNA
表达量低于轻度子痫前期孕妇(0.35±0.05 与 0.59±0.07,t=21.430,P<0.05),miR-191-5p mRNA 表达量高于轻度子痫前期孕妇(1.99±0.35 与 1.27±0.28,t=12.730,P<0.05)。miR-195、miR-191-5p 联合诊断子痫前期病情程度的曲线下面积(area under the curve,AUC)为 0.911(95% CI :0.803~0.945),诊断敏感度为 89.78%,特异度为 83.24%,明显优于任意单项预测。妊娠结局不良组孕妇外周血 miR-195 mRNA表达量低于妊娠结局良好组(0.28±0.04 与 0.65±0.08,t=26.060,P<0.05),miR-191-5p mRNA 表达量高于妊娠结局良好组(2.13±0.38 与 1.10±0.19,t=20.050,P<0.05)。Pearson 相关性分析结果显示,子痫前期孕妇外周血 miR-195 mRNA 表达量与妊娠结局呈负相关(r=-0.689,P<0.05);子痫前期孕妇外周血miR-191-5p mRNA 表达量与妊娠结局呈正相关(r=0.645,P<0.05)。miR-195、miR-191-5p 联合预测子痫前期妊娠结局的 AUC 为 0.954(95% CI :0.878~0.987),敏感度为 94.35%,特异度为 87.67%,明显优于任意单项预测。 结论  子痫前期孕妇外周血中 miR-195 呈低表达,miR-191-5p 呈高表达,与病情程度、妊娠结局有关,两者联合预测妊娠结局的效能较优。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词:  子痫前期  病情程度  微小 RNA-195  微小 RNA-191-5p  妊娠结局    
Abstract: 【Abstract】 Objective To study the relationship between microRNA-195 (miR-195) and microRNA-191-5P (miR-191-5p) in peripheral blood of pregnant women and the severity of preeclampsia, and the predictive value of combined detection of the two indicators for pregnancy outcomes. Method Using a prospective research method, 124 pregnant women with preeclampsia admitted to Chengdu Qingbaijiang District People's Hospital from January 2022 to June 2023 were included in the observation group, and 124 normal pregnant women who underwent prenatal examinations during the same period were selected as the control group. The expression levels of miR-195 and miR-191-5p mRNA in peripheral blood were detected by real-time fluorescence quantitative polymerase chain reaction (RT-qPCR), to analyze the differences in the expressions of miR-195 and miR-191-5p mRNA in peripheral blood of pregnant women with different severity of preeclampsia and pregnancy outcomes. The correlation of miR-195 and miR-191-5p mRNA expressions with severity of preeclampsia and pregnancy outcome, and the efficiency on predicting pregnancy outcome in pregnant women with preeclampsia were analyzed. Statistical analysis was performed by t-test, test, Pearson correlation analysis, receiver operating characteristic (ROC) curve analysis and multivariate Logistic regression analysis. Result The expression level of miR-195 mRNA in the peripheral blood of the observation group was lower than that of the control group (0.49±0.09 vs 1.00±0.12, t=37.860, 
P<0.05), while the expression level of miR-191-5p mRNA in the peripheral blood was higher than that of the control group (1.65±0.23 vs 1.00±0.10, t=28.860, P<0.05). The expression level of miR-195 mRNA in the peripheral blood of women with severe preeclampsia was lower than that of women with mild preeclampsia (0.35±0.05 vs 0.59±0.07, t=21.430, P<0.05), and the expression level of miR-191-5p mRNA was higher han that of pregnant women with mild preeclampsia (1.99±0.35 vs 1.27±0.28, t=12.730, P<0.05). The area under the curve (AUC) for the combined diagnosis of preeclampsia severity by miR-195 and miR-191-5p was 0.911 (95% CI: 0.803-0.945), with a sensitivity of 89.78% and a specificity of 83.24%, which was 
significantly better than any single predictor. The expression level of miR-195 mRNA in the peripheral blood of the adverse pregnancy outcome group was lower than that of the favorable pregnancy outcome group (0.28±0.04 vs 0.65±0.08, t=26.060, P<0.05), while the expression level of miR-191-5p mRNA was higher than that of the favorable pregnancy outcome group (2.13±0.38 vs 1.10±0.19, t=20.050, P<0.05). Pearson correlation analysis showed that the expression level of miR-195 mRNA in the peripheral blood of pregnant women with preeclampsia was negatively correlated with pregnancy outcomes (r=-0.689, P<0.05), while the expression level of miR-191-5p mRNA was positively correlated with pregnancy outcomes (r=0.645, P<0.05). The AUC for the combined prediction of preeclampsia pregnancy outcomes by miR-195 and miR-191-5p was 0.954 (95% CI: 0.878-0.987), with a sensitivity of 94.35% and a specificity of 87.67%, which was significantly better than any single predictor. Conclusion The low expression of miR-195 and high expression of miR-191-5p in the peripheral blood of pregnant women with preeclampsia are related to the severity of the preeclampsia and pregnancy outcome. The combination of the two indicators is more effective in predicting pregnancy outcome.
Key words:  Preeclampsia    Degree of illness    Micro RNA-195    Micro RNA-191-5p    Pregnancy outcome
                    发布日期:  2025-07-31     
基金资助: 四川省医学(青年创新)科研课题(S20225)
通讯作者:  李思琪    E-mail:  314565262@qq.com
引用本文:    
黄利  钱学飞  徐金凤  李思琪. 孕妇外周血 miR-195、miR-191-5p 与子痫前期病情程度的关系及联合预测妊娠结局的价值[J]. 发育医学电子杂志, 2025, 13(4): 261-267.
Huang Li, Qian Xuefei , Xu Jinfeng, et al. Relationship between miR-195, miR-191-5p in peripheral blood of pregnant women and the severity of preeclampsia, and the value of combined prediction of pregnancy outcomes. Journal of Developmental Medicine(Electronic Version), 2025, 13(4): 261-267.
链接本文:  
http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2025.04.003  或          http://www.fyyxzz.com/CN/Y2025/V13/I4/261
[1] 周菊梅 雷斐 刘新美 王少丽. 妊娠期高血压综合征孕妇低分子肝素联合小剂量阿司匹林治疗后出现不良妊娠结局的危险因素及风险预测模型[J]. 发育医学电子杂志, 2025, 13(3): 195-201.
[2] 娄娟 顾成敏 李洋 鲁会红 冯敏. 基于血清sTNFR- Ⅱ与血栓弹力图评价子痫前期病情及母儿并发症发生风险[J]. 发育医学电子杂志, 2025, 13(2): 120-127.
[3] 朱文丽 娄艳慧 赵玉玲. 血清NLR、PLR 在子痫前期孕妇中的表达及其与血压、24 h 尿蛋白、围产结局的关系[J]. 发育医学电子杂志, 2025, 13(2): 128-132.
[4] 山蕾 周涛 邱娟娟 倪晴 柏婷 彭兰. sFlt-1/PLGF 比值在子痫前期中的应用进展[J]. 发育医学电子杂志, 2025, 13(2): 154-160.
[5] 桂琦 侯伟 胡甲琳 姜淑芳 游艳琴 卢彦平. 系统性红斑狼疮与子痫前期因果关系的孟德尔随机化分析[J]. 发育医学电子杂志, 2024, 12(6): 415-421.
[6] 吴正沐 王正权 王旻 谈雅静 李文. 时差成像胚胎培养系统观察精子DNA碎片化指数对卵胞浆内单精子显微注射的胚胎发育及临床结局的影响[J]. 发育医学电子杂志, 2024, 12(2): 130-135.
[7] 李丹 杨小倩 曹雪萍. 贫血孕妇血清铁及可溶性血清转铁蛋白受体检测对妊娠结局的预测价值[J]. 发育医学电子杂志, 2024, 12(1): 30-35.
[8] 于怡清 周希亚 蒋宇林 吕嬿 常家祯 郝娜 李萌萌 戚庆炜. 16 例无创产前检测8 号染色体异常病例的产前诊断结果及妊娠结局分析[J]. 发育医学电子杂志, 2023, 11(5): 338-345.
[9] 胡婷婷 汪伟伟 胡益祥 张颖 蔡艳萍 颜宏利. 卵胞浆内单精子显微注射治疗周期中促性腺激素用药对胚胎发育潜能的影响[J]. 发育医学电子杂志, 2023, 11(3): 168-173.
[10] 曾贵红 邹伟洋 刘长娣 陈玉兰 温婷媚. 妊娠期特有并发症患者不同孕期脂代谢异质性及临床监测意义[J]. 发育医学电子杂志, 2023, 11(3): 174-180.
[11] 邹旷妮 姜春蓉 张素蓉. 孕中期子宫动脉多普勒超声血流参数联合血清学指标预测不良妊娠结局的价值[J]. 发育医学电子杂志, 2022, 10(3): 189-195.
[12] 郭玲玲 杨志清 王海星 张靓 郭燕青 郝崇奇 齐昊. 子痫前期对早产的影响及潜在交互作用[J]. 发育医学电子杂志, 2021, 9(6): 437-442.
[13] 韦秋圆 黄素静 王茹 马燕琳. 子痫前期患者胎盘微小RNA-30d 表达与内质网应激的相关性分析[J]. 发育医学电子杂志, 2021, 9(4): 287-291.
[14] 卢雪景 梁建梅 申林林 白娅琴 秦丽欣 高金霞 王亚凡. 低分子肝素联合小剂量阿司匹林对复发性流产患者血栓前状态、肝功能及免疫功能的影响[J]. 发育医学电子杂志, 2021, 9(3): 214-219.
[15] 曾带娣 李仲均 萧丽娟 黄素然.
子痫前期患者胎盘中微小 RNA-34a 的表达及相关机制
[J]. 发育医学电子杂志, 2020, 8(4): 329-332.
No Suggested Reading articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed